United Therapeutics Subsidiary
Appears in 1 story
Operator of centralized lung perfusion facilities
More than 8 in 10 donor lungs recovered from deceased donors never reach a patient. On June 29, 2026, the FDA approved a device built to change that math. United Therapeutics won premarket approval for LungFX, a system that keeps donor lungs warm, ventilated, and pumped with fluid outside the body so transplant teams can re-examine organs they had already rejected.
Updated 2 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
